TC Biopharm (Holdings) Statistics
Total Valuation
TCBP has a market cap or net worth of $2.82 million. The enterprise value is $3.79 million.
| Market Cap | 2.82M |
| Enterprise Value | 3.79M |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, after market close.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TCBP has 3.31 million shares outstanding. The number of shares has increased by 4,285.72% in one year.
| Shares Outstanding | 3.31M |
| Shares Change (YoY) | +4,285.72% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 0.61% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.02 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 1.60.
| Current Ratio | 0.88 |
| Quick Ratio | n/a |
| Debt / Equity | 1.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.72% in the last 52 weeks. The beta is 0.08, so TCBP's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -90.72% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 3.11 |
| Relative Strength Index (RSI) | 43.21 |
| Average Volume (20 Days) | 56,075 |
Short Selling Information
| Short Interest | 14,337 |
| Short Previous Month | 24,873 |
| Short % of Shares Out | 0.43% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | n/a |
| Net Income | n/a |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | -$19.77 |
Balance Sheet
The company has $1.27 million in cash and $2.23 million in debt, giving a net cash position of -$964,852 or -$0.29 per share.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 2.23M |
| Net Cash | -964,852 |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 1.40M |
| Book Value Per Share | 0.42 |
| Working Capital | -724,204 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TCBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4,285.72% |
| Shareholder Yield | -4,285.72% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 15, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Dec 15, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |